Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study

Cancer risk among insulin users: comparing analogues with human insulin in the CARING... Diabetologia (2017) 60:1691–1703 DOI 10.1007/s00125-017-4312-5 ARTICLE Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study 1 2,3 2 4 Anna But & Marie L. De Bruin & Marloes T. Bazelier & Vidar Hjellvik & 5,6,7 8 9 Morten Andersen & Anssi Auvinen & Jakob Starup-Linde & 10,11 4 2,12,13,14 Marjanka K. Schmidt & Kari Furu & Frank de Vries & 4 5 1 Øystein Karlstad & Nils Ekström & Jari Haukka Received: 13 December 2016 /Accepted: 24 April 2017 /Published online: 1 June 2017 The Author(s) 2017. This article is an open access publication Abstract regression models. For each of ten cancer sites studied, we Aims/hypothesis The aim of this work was to investigate the estimated the rate ratios (RRs) by duration (≤0.5, 0.5–1, 1–2, relationship between use of certain insulins and risk for cancer, 2–3, 3–4, 4–5, 5–6 and >6 years) of cumulative exposure to when addressing the limitations and biases involved in previ- insulin glargine or insulin detemir relative to that of human ous studies. insulin. Methods National Health Registries from Denmark Results A total of 21,390 cancer cases occurred during a mean (1996–2010), Finland (1996–2011), Norway (2005–2010) follow-up of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Diabetologia Springer Journals

Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study

Loading next page...
 
/lp/springer_journal/cancer-risk-among-insulin-users-comparing-analogues-with-human-insulin-nwgzaohfm8
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine; Metabolic Diseases; Human Physiology
ISSN
0012-186X
eISSN
1432-0428
D.O.I.
10.1007/s00125-017-4312-5
Publisher site
See Article on Publisher Site

Abstract

Diabetologia (2017) 60:1691–1703 DOI 10.1007/s00125-017-4312-5 ARTICLE Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study 1 2,3 2 4 Anna But & Marie L. De Bruin & Marloes T. Bazelier & Vidar Hjellvik & 5,6,7 8 9 Morten Andersen & Anssi Auvinen & Jakob Starup-Linde & 10,11 4 2,12,13,14 Marjanka K. Schmidt & Kari Furu & Frank de Vries & 4 5 1 Øystein Karlstad & Nils Ekström & Jari Haukka Received: 13 December 2016 /Accepted: 24 April 2017 /Published online: 1 June 2017 The Author(s) 2017. This article is an open access publication Abstract regression models. For each of ten cancer sites studied, we Aims/hypothesis The aim of this work was to investigate the estimated the rate ratios (RRs) by duration (≤0.5, 0.5–1, 1–2, relationship between use of certain insulins and risk for cancer, 2–3, 3–4, 4–5, 5–6 and >6 years) of cumulative exposure to when addressing the limitations and biases involved in previ- insulin glargine or insulin detemir relative to that of human ous studies. insulin. Methods National Health Registries from Denmark Results A total of 21,390 cancer cases occurred during a mean (1996–2010), Finland (1996–2011), Norway (2005–2010) follow-up of

Journal

DiabetologiaSpringer Journals

Published: Jun 1, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off